Introduction
Renal osteodystrophy encompasses the bone histologic abnormalities seen in patients with chronic kidney disease (CKD). The bone-specific alkaline phosphatase (BALP) isoform B1x is exclusively found in serum of some CKD patients. The aim of this study was to examine the relationship between serum BALP isoform activities and histomorphometric parameters of bone in patients with CKD on chronic dialysis.
Methods
Anterior iliac crest bone biopsy samples from 40 CKD patients were selected on the basis of bone turnover for histomorphometric analysis. There were samples from 20 patients with low and 20 with non-low bone turnover. In serum, BALP, BALP isoforms (B/I, B1x, B1 and B2), and parathyroid hormone (PTH) were measured.
Results
B1x was found in 21 patients (53%). They had lower levels of BALP, other BALP isoforms, and PTH compared to patients without B1x. B1x correlated inversely with osteoblast number and activity. ROC curves showed that B1x was superior to PTH and BALP to diagnose low osteoblast activity. Osteoblast vigor (%/day) 0.49 (0.23-0.62) 0.14 (0.02-0.37) * Data are expressed as median (lower quartile to higher quartile). * p < 0.05; # p < 0.01
Conclusion
The study shows that B1x is a novel diagnostic parameter for osteoblastic insufficiency as illustrated by superior ROC curve AUC compared toPTH and BALP. This indicates that the release of B1x into serum from bone is a sign of perturbed osteoblast activity. 
